Products Pens Vials Research FAQ Order Now
Research Guide

Weight Loss Peptides in the UK

Nova Biolabs stocks the main peptides used in weight-management research — Tirzepatide, Retatrutide, Semaglutide and Cagrilintide — domestically in the UK, with same or next-day dispatch in discreet packaging. Here's how they differ and how to pick the right one for your research.

The weight-management research peptides, at a glance

Most of what's searched for as "weight loss peptides" falls into two families: incretin receptor agonists (GLP-1, GIP and glucagon-based compounds) and amylin receptor agonists. They work on different pathways, and the incretin family in particular has expanded quickly — each new compound adding another receptor to the mechanism.

CompoundReceptors targetedFrom
SemaglutideGLP-1 (single)£20
TirzepatideGLP-1 + GIP (dual)£30
RetatrutideGLP-1 + GIP + Glucagon (triple)£35
CagrilintideAmylin (long-acting)£45

Semaglutide — the single-receptor baseline

Semaglutide targets the GLP-1 receptor only, making it the reference compound most other incretin research is benchmarked against. It's the longest-studied of the four and the starting point for understanding GLP-1 receptor pharmacology before layering in additional receptor activity.

Tirzepatide — dual agonism

Tirzepatide adds GIP receptor agonism to GLP-1, engaging two incretin pathways simultaneously. This dual mechanism is of particular research interest for studying how the two receptors interact rather than act independently. Full Tirzepatide guide →

Retatrutide — triple agonism

Retatrutide goes a step further, adding glucagon receptor agonism on top of GLP-1 and GIP. The glucagon component is what distinguishes it — it engages hepatic glucose output and energy expenditure pathways that dual agonists don't directly touch. Full Retatrutide guide →

Cagrilintide — a different mechanism entirely

Cagrilintide isn't an incretin analogue at all — it's a long-acting amylin receptor agonist. Amylin is co-secreted with insulin and acts on satiety signalling through a separate pathway, which is why Cagrilintide is often studied alongside a GLP-1 compound rather than as a substitute for one. View Cagrilintide 10mg →

There's no single "strongest" compound here — each targets a different combination of receptors, and which one is right for a given research protocol depends on which pathway you're actually studying, not just how many receptors a compound engages.

Storage and reconstitution

All four are supplied lyophilised and require reconstitution with bacteriostatic water before use. Store at 2–8°C away from light, use the peptide dosing calculator for exact measurements, and use reconstituted material within 28 days. See the full reconstitution guide for detail.

Order from UK Domestic Stock

All Nova Biolabs peptides are research grade, held in UK stock for same or next-day dispatch.

Browse All Products →

Related Products

Frequently Asked Questions

Where can I buy weight loss peptides in the UK?
Nova Biolabs stocks the main GLP-1/GIP weight-management research compounds — Tirzepatide, Retatrutide, Semaglutide and Cagrilintide — domestically in the UK, with same or next business day dispatch and discreet packaging. Every batch is independently lab-tested for purity, verifiable on the Nova Biolabs site.
What is the strongest weight loss peptide?
Of the compounds studied for weight management, Retatrutide is the broadest-acting: it engages three receptors (GLP-1, GIP and glucagon) versus Tirzepatide's two (GLP-1 and GIP) and Semaglutide's one (GLP-1 only). Broader receptor engagement in research settings is generally associated with a larger effect, but each compound has a distinct pharmacological profile worth understanding on its own terms rather than assuming more receptors simply means better.
What is the difference between Tirzepatide, Retatrutide, Semaglutide and Cagrilintide?
Semaglutide is a single-receptor GLP-1 agonist. Tirzepatide adds GIP receptor agonism alongside GLP-1. Retatrutide goes further, adding glucagon receptor agonism for a triple-agonist profile. Cagrilintide works differently again, as a long-acting amylin receptor agonist rather than an incretin analogue, and is often studied alongside a GLP-1 compound rather than instead of one.
Do I need a prescription for research peptides?
Nova Biolabs products are sold exclusively for in vitro laboratory research use, not as medicines, so no prescription applies. They are not approved medications and are not intended for human or veterinary use.
Research use only. All Nova Biolabs products are sold strictly for in vitro laboratory and research purposes only. They are not intended for human consumption, medical use, or veterinary use. Not for use on or by humans or animals. For qualified researchers only. Must be 18+.